Rockwell Medical, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RMTI research report →
Companywww.rockwellmed.com
Rockwell Medical, Inc. , together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores.
- CEO
- Mark Strobeck
- IPO
- 1998
- Employees
- 244
- HQ
- Wixom, MI, US
Price Chart
Valuation
- Market Cap
- $32.37M
- P/E
- -0.02
- P/S
- 0.00
- P/B
- 0.90
- EV/EBITDA
- -0.03
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 16.71%
- Op Margin
- -8.53%
- Net Margin
- -9.25%
- ROE
- -4587.82%
- ROIC
- -2952.08%
Growth & Income
- Revenue
- $69.26M · -31.76%
- Net Income
- $-5,314,000 · -1007.08%
- EPS
- $-0.15 · -495.24%
- Op Income
- $-4,691,000
- FCF YoY
- -137.64%
Performance & Tape
- 52W High
- $2.10
- 52W Low
- $0.74
- 50D MA
- $0.90
- 200D MA
- $1.05
- Beta
- 1.65
- Avg Volume
- 259.47K
Get TickerSpark's AI analysis on RMTI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 20, 25 | Neri Jesse | other | 97,500 |
| May 20, 25 | TIMMINS MEGAN C. | other | 97,500 |
| May 20, 25 | Chole Timothy | other | 85,000 |
| May 20, 25 | Strobeck Mark | other | 352,000 |
| Mar 14, 26 | Hunter Heather | other | 2,444 |
| Mar 14, 26 | TIMMINS MEGAN C. | other | 3,667 |
| Mar 14, 26 | Neri Jesse | other | 2,444 |
| Mar 14, 26 | Chole Timothy | other | 2,444 |
| Mar 14, 26 | Strobeck Mark | other | 7,333 |
| Jan 2, 26 | Hunter Heather | sell | 2,868 |
Our RMTI Coverage
We haven't published any research on RMTI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RMTI Report →